Elevated depressive symptoms among newer and younger healthcare workers in Japan during the COVID-19 pandemic.


Journal

Neuropsychopharmacology reports
ISSN: 2574-173X
Titre abrégé: Neuropsychopharmacol Rep
Pays: United States
ID NLM: 101719700

Informations de publication

Date de publication:
12 2021
Historique:
revised: 20 10 2021
received: 19 01 2021
accepted: 20 10 2021
pubmed: 4 11 2021
medline: 5 1 2022
entrez: 3 11 2021
Statut: ppublish

Résumé

Depression is a frequent outcome of long-term stress, but no studies have examined depression rates among Japanese healthcare workers fighting the COVID-19 pandemic. Therefore, we conducted a web-based interview of hospital employees to assess depression prevalence and factors. This observational cohort study was conducted from July to August, 2020, as part of a mandatory health checkup of Juntendo University Hospital employees (Tokyo, Japan). A total of 4239 participants completed a web-based questionnaire on medical history and current health status. The Center for Epidemiologic Studies Depression Scale (CES-D) was used for self-assessment, with a score of ≥16 considered to indicate depression. Among all employees, the proportion of depression was 31.3% in 2020, the highest measured in the last 10 years and substantially greater than the pre-pandemic value in 2019 (27.5%). The proportion of depression for 2020 was significantly higher in new recruits than in employees with more than 2 years of experience (47.0% vs 29.9%, respectively, P < .0001) and in new recruits in 2019 (26.4%, P < .0001). When subdivided by occupation, nurses demonstrated the highest depression rate (43.2%), followed by paramedics (35.1%) and clerks (31.6%), whereas residents (22.9%), doctors (20.4%), teaching staff (18.0%), and part-time staff (15.3%) reported lower depression rates. The positive CES-D score significantly correlated with age (P < .0001). Younger and newer employees demonstrated the highest rates of depression independent of occupation. Therefore, mental healthcare programs focusing on these vulnerable groups need to be established.

Identifiants

pubmed: 34730870
doi: 10.1002/npr2.12217
pmc: PMC8646441
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

544-547

Subventions

Organisme : Juntendo Institute of Mental Health
ID : 201701

Informations de copyright

© 2021 The Authors. Neuropsychopharmacology Reports published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society of Neuropsychopharmacology.

Références

BMC Psychiatry. 2021 Jan 12;21(1):33
pubmed: 33435930
BMJ. 2020 May 5;369:m1815
pubmed: 32371465
Psychiatry Clin Neurosci. 2020 Sep;74(9):505-506
pubmed: 32609413
Neuropsychopharmacol Rep. 2021 Dec;41(4):544-547
pubmed: 34730870
Scand J Work Environ Health. 2020 Nov 1;46(6):639-644
pubmed: 32905601
J Affect Disord. 2020 Dec 1;277:55-64
pubmed: 32799105
Nat Hum Behav. 2021 Feb;5(2):229-238
pubmed: 33452498
JAMA Netw Open. 2020 Mar 2;3(3):e203976
pubmed: 32202646
Lancet. 2020 Mar 14;395(10227):912-920
pubmed: 32112714
Eur Heart J Acute Cardiovasc Care. 2020 Apr;9(3):241-247
pubmed: 32342698
J Affect Disord. 2020 Oct 1;275:48-57
pubmed: 32658823

Auteurs

Narimasa Katsuta (N)

Department of Psychiatry, Juntendo University Faculty of Medicine, Japan.
Department of Safety and Health Promotion, Juntendo University, Bunkyo-ku, Japan.

Kanami Ito (K)

Department of Safety and Health Promotion, Juntendo University, Bunkyo-ku, Japan.

Hiroshi Fukuda (H)

Department of Safety and Health Promotion, Juntendo University, Bunkyo-ku, Japan.
Department of General Medicine, Juntendo University Graduate School of Medicine, Bunkyo-ku, Japan.

Kuniaki Seyama (K)

Department of Safety and Health Promotion, Juntendo University, Bunkyo-ku, Japan.
Division of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Bunkyo-ku, Japan.

Satoshi Hori (S)

Department of Safety and Health Promotion, Juntendo University, Bunkyo-ku, Japan.
Division of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Bunkyo-ku, Japan.

Yuka Shida (Y)

Department of Safety and Health Promotion, Juntendo University, Bunkyo-ku, Japan.

Rie Nagura (R)

Department of Safety and Health Promotion, Juntendo University, Bunkyo-ku, Japan.

Shuko Nojiri (S)

Medical Technology Innovation Center, Juntendo University, Bunkyo-ku, Japan.

Hiroyuki Sato (H)

Department of Safety and Health Promotion, Juntendo University, Bunkyo-ku, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH